Next Investors logo grey

Roto-Gro sales agreement triggers 30% share price jump

Published 04-OCT-2017 16:59 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Roto-Gro World Wide (Canada) Inc., a wholly-owned subsidiary of Roto-Gro International (ASX:RGI), announced last week that it had received a C$1.1 million purchase order for 100 Roto-Gro Systems from Amfil Technologies Inc. (OTC:AMFE).

This purchase order further consolidates the existing collaborative relationship with Amfil for the integration of its proprietary GRO3 Antimicrobial System with the Roto-Gro Garden, providing enhanced cultivation solutions for medical cannabis and indoor farming industries.

As a backdrop, RGI is an Australian based company with a worldwide exclusive license to manufacture and distribute the Roto-Gro system, an advanced automated Rotary hydroponic vertical farming system. The system can be rolled out to medical cannabis producers, as well as distributors and resellers.

The company also has a worldwide license to distribute the system for all other purposes including pharmaceuticals, health and nutrition supplements, nutraceuticals and perishable foods. Management’s strategy is to focus on expanding into industries that offer synergies, either by forging strategic partnerships or making acquisitions.

Potential investors should note that RGI is still in its early stages and therefore any decision with regards to adding this stock to your portfolio should be taken with caution and professional financial advice sought.

Amfil purchase order triggers share price spike

The receipt of the purchase order from Amfil has triggered a significant share price rerating. Since the announcement, RGI’s shares have increased nearly 30% from 26 cents to 33.5 cents Wednesday morning.

There is the potential for flow on success from this transaction as collaborative initiatives undertaken with Amfil have resulted in an impressive pipeline of prospective clients seeking the significant space, cost and yield advantages of the Roto-Gro System, together with the EcoPrO3 GRO3 all-natural solution to the contamination issues recently plaguing the medical cannabis industry.

The 100 unit purchase order will be allocated to a 4000 square feet portion of a soon-to-be-licensed Canadian cannabis cultivator with a view to producing organic cannabis products in Ontario, Canada.

The client also operates a non-cannabis nursery of perishable foods covering approximately 150,000 square feet contained in several buildings on a single property. RGI is currently discussing the design of a proprietary Rotary Gardens solution for the client’s perishable food operations and will assist it with a staged roll-out of a portion of these premises for perishable foods utilizing the Roto-Gro System together with the EcoPr03 GR03.

Roto-Gro has potential to harness further growth through value-added services

Commenting on these developments, Managing Director of Roto-Gro International, Michael Carli said, “We are very excited about our collaboration with Amfil Technologies Inc. and Amfil’s initial purchase order as it demonstrates the group’s excellent reputation, having played an active role in the food and beverage industry for over twenty years, servicing numerous multinational corporations including Pepsi, Sysco, Sun Pacific and Nestle”.

Given this backdrop, Carli is of the view that this purchase order is the first of many leads developed by the Roto-Gro and Amfil collaboration, providing a platform for strong future sales growth.

Carli also noted that RGI’s in-house design expertise and proprietary technology sets the group apart from its competitors. The company will continue working on collaborative ventures with the expectation that its sales pipeline will drive shareholder value through further sales orders and growth in management valued-added services.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.